EICHOR
● Not Yet Recruiting
Growth Hormone Resistance of Beta-cells
Condition: Healthy · Obesity & Overweight · Impaired Fasting Glucose (IFG) · Sponsor: University of Missouri-Columbia
About this study
The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with impaired fasting glucose or impaired glucose tolerance at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing type 2 diabetes.
This description comes directly from the study's public registry record.
Talk to the study team
Study Coordinator · 573-884-6852 · ahmc4@health.missouri.edu
Vasavi Shabrish · v.shabrish@missouri.edu
Always discuss trial participation with your own doctor first.
Locations (1)
| University of Missouri School of Medicine | Columbia, Missouri, United States | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07581860